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Abstract
Background: Both obesity and gestational diabetes mellitus are increasing in prevalence, being a major health
problem in pregnancy with independent and additive impact on obstetrics outcomes. It is recognized that
inadequate gestational weight gain is an independent risk factor for pregnancy-related morbidity. The aim of this
study was to evaluate the effect of gestational weight gain on obstetric and neonatal outcomes in obese women
with gestational diabetes.
Methods: Retrospective multicenter study of obese women with gestational diabetes. The assessed group was
divided into three categories: women who gained below (<5 kg), within (5–9 kg) and above (>9 kg) the 2009
Institute of Medicine recommendations. Maternal and neonatal outcomes were compared and adjusted odds ratios
calculated controlling for confounders.
Results: Only 35,1 % of obese women with gestational diabetes (n = 634) achieved the recommended gestational
weight gain; 27,8 % (n = 502) gained below and 37,1 % (n = 670) above the recommendations. There was a
positive correlation between gestational weight gain and neonatal birthweight (r = 0,225; p < 0,001). Gestational
weight gain below recommendations was associated with lower odds for cesarean section, even adjusting for
birthweight [aOR = 0,67 (0,54–0,85); p < 0,001]; lower odds for large for gestational age neonates [aOR = 0,39
(0,28–0,57); p < 0,001] and macrosomia [aOR = 0,34 (0,21–0,55); p < 0,001]. Excessive weight gain, even adjusting
for birthweight, was associated with higher odds for cesarean section [aOR = 1,31 (1,07–1,61); p = 0,009], low Apgar
score [aOR = 4,79 (1,19–19,21); p = 0,027], large for gestational age neonates [aOR = 2,32 (1,76–3,04); p < 0,001] and
macrosomia [aOR = 2,39 (1,68–3,38); p < 0,001].
Conclusions: In obese women with gestational diabetes, a reduced gestational weight gain (<5 kg) is associated with
better obstetric and neonatal outcomes than an excessive or even an adequate weight gain. Therefore, specific
recommendations should be created since gestational weight gain could be a modifiable risk factor for adverse
obstetric outcomes.
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Background
Both obesity and gestational diabetes mellitus (GDM)
are increasing in prevalence, being a major health prob-
lem in pregnancy [1–4].
Obesity (defined as body mass index (BMI) ≥ 30 kg/m2)
is a chronic illness which prepregnancy incidence is
around 20 % [2–6]. It is an independent risk factor for ob-
stetric complications, such as congenital abnormalities,
GDM, preeclampsia, large for gestational age (LGA) and
macrosomic newborns, fetal distress, low Apgar scores
and cesarean sections [2, 4, 5, 7–10].
GDM is one of the most common medical complica-
tions of pregnancy [11]. The obstetric complications as-
sociated are well-known: preterm labor, preeclampsia,
LGA and macrosomia, growth restriction, birth
trauma, cesarean section, neonatal hypoglycemia,
among others. [2, 4, 5, 7, 8, 11].
The impact of maternal obesity and GDM on ob-
stetrics outcomes appears to be independent and addi-
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It is recognized that inadequate gestational weight gain
(GWG) is an independent risk factor for pregnancy-
related morbidity. Overall and in obese women, exces-
sive early GWG is associated with adverse pregnancy
outcomes including GDM, cesarean section and LGA
[12–15]; insufficient GWG has been (although not
consistently) associated with small for gestational age
(SGA) newborns [13–16].
In 2009, the Institute of Medicine (IOM) updated
guidelines for GWG, formulated as a range for each
category of prepregnancy BMI. In obese women, the
recommended range for GWG is 5–9 kg [17]. However,
no coexisting pregnancy complications (such as GDM)
were considered in these guidelines.
In women with GDM, recent data have shown that
excessive GWG confers an additional risk for LGA,
macrosomia, gestational hypertension, cesarean section
and low Apgar scores [10, 18]. Therefore, prevention of
excessive GWG has the potential to reduce these adverse
obstetric outcomes [10].
Furthermore, there are some studies that suggest that
a GWG below IOM recommendations in overweight
and obese women with GDM could result in more favor-
able pregnancy outcomes without an increase in SGA
risk [19, 20].
Considering these data, we hypothesized that in obese
women with GDM, the intervention on GWG could
have a relevant impact on obstetrics outcomes: excessive
GWG confers an additional risk for adverse outcomes;
insufficient GWG decreases the risk of adverse out-
comes. In this study we will describe the effects of ex-
cessive, adequate and insufficient GWG (defined using
IOM criteria) within a cohort of obese women diagnosed
with GDM.
Methods
A retrospective cohort study of Portuguese obese
pregnant women with GDM who delivered between
2008 and 2012. Data were obtained from the analysis of
the National Registry of GDM concerning these years
(n = 8441) after permission from the Study Group of the
Portuguese Society of Diabetology (Sociedade Portuguesa
de Diabetologia), who coordinates this National Registry.
Data are voluntarily and anonymously collected from clin-
ical records of women with GDM, by multidisciplinary
teams of Obstetrics and Diabetology, in 25 (of the 44)
public Portuguese health institutions. These data sets are
aggregated and validated by the Study Group of the
Portuguese Society of Diabetology, according to the data
provided by Portuguese Directorate-General of Health
(Direção Geral de Saúde). Subsequently, the data sets are
blinded relatively to the patients and hospitals’ identifica-
tions in order to unable investigators to identify the sub-
jects and to maintain anonymity. All clinical investigations
were conducted according to the principles expressed in
the Declaration of Helsinki.
The GDM diagnosis was established using the criteria
recommended by the Portuguese Directorate-General of
Health. Until February 2011, the recommended GDM
diagnosis was based on Carpenter and Coustan’s criteria
[21]. After February 2011, the recommended diagnosis
has been based on the International Association of Dia-
betes Pregnancy Study Groups’ criteria [22]. Each woman
received detailed education on diet, exercise and appropri-
ate glycemic targets (through self-directed glucose moni-
toring). Women were reviewed periodically depending on
the stage of pregnancy. At each visit weight was measured
and an assessment of previous blood glucose readings
were made (insulin was started if they were outside the
following ranges on more than 10 % of the measures:
fasting glucose > 90 mg/dL or a 1 h postprandial reading
of > 120 mg/dL).
The inclusion criteria include prepregnancy obesity
(BMI ≥ 30 kg/m2). Prepregnancy BMI was calculated
from self-reported prepregnancy weight and height.
Women with missing GWG values and women with
twin pregnancy were excluded.
GWG for the entire pregnancy was calculated and
considering the 2009 IOM recommendations for obese
women, we subsequently divided the assessed group into
three categories: women who gained below (<5 kg),
within (5–9Kg) and above (>9 kg) the IOM limits.
Neonates with a birthweight above the 90th percentile
for gestational age were considered LGA, while those
with a birthweight below the 10th percentile for gesta-
tional age were considered SGA [23]. Neonates with a
birthweight > 4000 g were considered macrosomic. Ges-
tational age was determined at the booking visit using
obstetric ultrasound.
The analyzed data included biometric and demo-
graphic parameters, obstetric history, gestational age at
diagnosis, need for insulin therapy, GWG, obstetric
complications (such as preterm labor and cesarean sec-
tion) and neonatal outcomes (including gestational age
at delivery, birth weight, APGAR score, morbidities and
admission to the intensive care unit).
Data were analyzed using STATA version 13.1. GWG
was modeled as continuous and categorical variables
(below, within and above IOM limits) to explain neo-
natal and maternal outcomes. We compared the ob-
stetric, maternal and neonatal outcomes on the three
categories (below, within and above IOM limits) using
χ2 test to assess the differences in proportions and
ANOVA to compare the means of continuous variables.
Multivariate analyses were performed and adjusted odds
ratio (aOR) were calculated using stepwise backward
logistic regression models, adjusted for the following co-
variates: age, parity, prepregnancy BMI, use of insulin,
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gestational age at delivery, and birthweight (when
appropriated). Data are expressed as proportions, means
(±SD of the mean), adjusted odds ratios (aORs), and 95 %
confidence intervals (CI). Statistical significance was ac-
cepted when the 95 % CI did not contain one (regression
analyses). Significance was considered for p < 0,05.
Results
The total cohort of the National Registry of GDM in-
cluded 26 % (n = 2007) obese women (in a total of 7703
with registered prepregnancy BMI). After further exclu-
sion of women with missing GWG values and with twin
pregnancy, 1806 women met the eligibility criteria.
Only 35,1 % of obese women with GDM (n = 634)
achieved the recommended GWG; 27,8 % (n = 502)
gained below and 37,1 % (n = 670) gained above the
IOM recommendations.
Table 1 summarizes, per category of GWG, the data
on their demographics, rates of women on insulin ther-
apy, delivery and neonatal outcomes.
Pregnant women who gained below the IOM limits
had a higher prepregnancy BMI than the rest of the
study population (p < 0,01).
The mean overall weight gain was 8,1 ± 6,3 kg. How-
ever, 4,6 % (n = 84) of obese women with GDM lost
weight (−4,3 ± 3,7 kg).
Gestational age at delivery and the rates of preterm de-
livery (before 37 weeks) were similar in the three
weight-gain groups (p > 0.05).
In obese women with GDM, the cesarean rate was
significantly higher (48,1 %) than in total women of the
National Registry of GDM (including all BMI’s categories)
(37,2 %) (p < 0,01). Nevertheless, in obese women with
GDM: when comparing with adequate GWG, rates of
cesarean section were significantly lower in the group with
GWG below IOM limits (40,6 %; p < 0,05), and even
lower in the subgroup with gestational weight loss
(27,2 %; p < 0,01).
Regarding neonatal birthweight, there was a positive
correlation between GWG and neonatal birthweight
(r = 0,225; p < 0,001). When compared with adequate
GWG, birthweight was significantly lower in the group
with insufficient GWG (p < 0,01) and significantly higher
in the group with excessive GWG (p < 0,01).
LGA and macrosomic neonates were more common
in the group with greater GWG (p < 0,01 and p < 0,05,
respectively).
SGA neonates were more common in the group with
GWG below IOM limits (7,8 %; p < 0,05); however, rates
were similar between the subgroup with GWG between
0 and 5 kg and the subgroup with gestational weight loss
(7,9 % versus 7,4 %; p > 0,05).
Table 1 Characteristics of the study group (obese women with GDM)
Total study group
(n = 1806)
GWG below IOM limits (<5 kg)
(n = 502)
GWG within IOM limits (5–9 kg)
(n = 634)
GWG above IOM limits (>9 kg)
(n = 670)
Age (years) 33.1 ± 5.0 33.4 ± 4.8 33.5 ± 4.9 32.5 ± 5.2**
Parity = 0 38.4 % (n = 694) 38.1 % (n = 191) 37.5 % (n = 238) 39,6 % (n = 265)
≥ 1 61.6 % (n = 1112) 61.9 %(n = 311) 62.5 % (n = 296) 60,4 % (n = 405)
Prepregnancy BMI (kg/m2) 34.7 ± 4.2 35.5 ± 4.5** 34.7 ± 4.1 34.1 ± 3.9
GWG (total) (kg) 8.1 ± 6.3 1.2 ± 3.2** 6.9 ± 1.3 14.3 ± 4.7**
Insulin therapy 47.2 % (n = 853) 50.2 % (n = 252) 45.9 % (n = 291) 46.3 % (n = 310)
Delivery (weeks) 38.4 ± 1.6 38.3 ± 1.8 38.3 ± 1.6 38.4 ± 1.4
Preterm labour 6.8 % (n = 123) 7.0 % (n = 35) 7.7 % (n = 49) 5.8 % (n = 39)
Delivery
Normal delivery 40.5 % (n = 715) 47.8 % (n = 231)* 39.7 % (n = 247) 36.0 % (n = 237)
Instrumental delivery 11.4 % (n = 201) 11.6 % (n = 56) 11.4 % (n = 71) 11.2 % (n = 74)
Cesarean section 48.1 % (n = 849) 40.6 % (n = 196)* 48.9 % (n = n = 305) 52.8 % (n = 348)
Neonatal birthweight (g) 3312 ± 560 3169 ± 537** 3284 ± 560 3442 ± 548**
LGA (>p90) 15.8 % (n = 274) 9.1 % (n = 43) 14.2 % (n = 87) 22.3 % (n = 144)**
Macrosomic 9.0 % (n = 157) 4.6 % (n = 22) 8.2 % (n = 51) 12.8 % (n = 84)*
SGA (<p10) 4.9 % (n = 85) 7.8 % (n = 37)* 4.6 % (n = 28) 3.1 % (n = 20)
Neonatal morbidities 19.4 % (n = 295) 18.4 % (n = 73) 18.4 % (n = 98) 21.1 % (n = 124)
Admission to the intensive
unit care
3.1 % (n = 48) 3.9 % (n = 16) 2.9 % (n = 16) 2.7 % (n = 16)
Data are expressed as mean ± SD and percentage and number of patients (in parentheses) of the total group
*p < 0.05 **p < 0.01 (both GWG below and GWG above IOM limits were compared with GWG within IOM limits)
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No differences in neonatal morbidities were found
between the three weight-gain groups (p > 0,05).
Using multivariable analysis, GWG below IOM
limits was associated with lower odds for cesarean
section, even adjusting for birthweight [aOR 0,67
(0,54–0,85); p < 0,001]. Furthermore, it was associated
with lower odds for LGA [aOR 0,39 (0,28–0,57); p < 0,001]
and of macrosomia [aOR 0,34 (0,21–0,55); p < 0,001]
(Table 2).
On the other hand, GWG above IOM limits, even
adjusting for birthweight, was associated with higher odds
for cesarean section [aOR 1,31 (1,07–1,61); p 0,009] and
of low Apgar score [aOR 4,79 (1,19–19,21); p 0,027]. It
was also associated with higher odds for LGA [aOR 2,32
(1,76–3,04); p < 0,001] and of macrosomia [aOR2,39
(1,68–3,38); p < 0,001] (Table 2).
Discussion
GDM, obesity and excessive GWG represent, individu-
ally and additively, high-risk conditions associated with
adverse maternal and neonatal outcomes [2, 4, 5, 10, 24].
Women with excessive GWG were predominantly
younger. As mentioned in a recent study [18], these data
suggest that older women may be more likely to comply
with lifestyle recommendations during pregnancy.
Overall, despite a regular multidisciplinary interven-
tion program, more than a third of women with obesity
and GDM gained excessive weight during pregnancy.
The rate of insulin treatment was similar in all three
weight-gain groups, which suggests that glycemic con-
trol was similarly reached during the pregnancies.
In this high-risk group, we realized that GWG above
IOM limits is significantly associated with an additive
risk for LGA and macrosomia. These data are consistent
with other authors who have shown similar effects of ex-
cessive GWG on birthweight for mixed populations of
pregnant women [10, 12–14, 24] and specifically for
women with GDM [18, 19]. LGA and macrosomic new-
borns had been associated with adverse short-term
outcomes, such as an increased risk of instrumental
vaginal delivery, emergency cesarean section, shoulder
dystocia, fetal birth injury, postpartum hemorrhage,
Apgar score <4 and admission to the intensive care unit
and adverse long-term outcomes like childhood obesity,
metabolic syndrome and cancer [4, 5, 7].
Additionally, we demonstrate that excessive GWG is
significantly associated with an additional risk of cesarean
section and low Apgar scores (5 min Apgar <7), even after
adjusting for other factors including birthweight. A higher
rate of cesarean section associated with excessive
GWG has already been described in the general popula-
tion [9, 12, 24], obese women [14, 15] and obese women
with GDM [19]. This increased risk of cesarean section in
obese women with GDM must be avoided because, not
only does it pose immediate operative risks but it is also
associated with post-operative complications such as
wound infection or dehiscence, excessive blood loss, deep
venous thrombosis and postpartum endometritis [4].
Thus, preventing excessive GWG is imperative. Con-
sidering the inherent difficulties of this high-risk group,
preventing excessive GWG may be more feasible than
prevention of obesity and GDM, as it is monitored
during pregnancy.
Reduced GWG (<5 kg), in obese women with GDM, is
significantly associated with a decreased risk of LGA and
macrosomia, when adjusted for other relevant factors.
Although the risk of SGA is increased in this group,
using adequate percentiles birthweight curves to our
population (published in 2011, by Pedreira et al. [23]),
we verify that this risk is equivalent to the risk of SGA
in low-risk pregnancies.
In addition, GWG below IOM recommendations,
especially with weight loss, leads to a marked reduction
in cesarean section rates and in all its possible associated
complications.
These data support some previous studies which
propose that reduced GWG (below IOM thresholds)
leads to better maternal and neonatal outcomes in
Table 2 Multivariable analysis of adverse outcomes associated with GWG (below versus above IOM limits) in obese women
with GDM
Adverse outcomes GWG below IOM limits (<5 kg) GWG above IOM limits (>9 kg)
aOR (95 % CI) p value aOR (95 % CI) p value
Cesarean sectiona 0.67 (0.54–0.85) 0.001 1.31 (1.07–1.61) 0.009
LGAb 0.39 (0.28–0.57) <0.001 2.32 (1.76–3.04) <0.001
Macrosomiab 0.34 (0.21–0.55) <0.001 2.39 (1.68–3.38) <0.001
SGAb 2.14 (1.36–3.35) 0.001 0.53 (0.31–0.88) 0.015
Low Apgar scorea 0.14 (0.01–1.33) >0.05 4.79 (1.19–19.21) 0.027
Admission to the intensive unit carea 1.38 (0.71–2.68) >0.05 0.81 (0.42–1.54) >0.05
aAdjusted for: age, parity, prepregnancy BMI, use of insulin, gestational age at delivery and birthweight (except for the aORs of the outcomes LGA, macrosomia
and SGA)
bAdjusted for: age, parity, prepregnancy BMI, use of insulin, gestational age at delivery
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obese women [14, 25] as well as obese women with
GDM [19, 20].
This study has limitations and among them is that it
was not nationwide (it covered 25 of 44 units) and pre-
pregnancy BMI was measured using self-reported infor-
mation (prepregnancy weight and height), which may
have been erroneous. However, there is evidence that
self-reported pregnancy data tend to be accurate [26].
Also, 8.7 % (n = 738) of the pregnant women with GDM
were excluded from the original cohort for missing pre-
pregnancy BMI. In addition, GDM official recommenda-
tions for diagnosis and recommendations for GWG
changed during the study period (respectively, 2011 and
2009) which may have affected some of our outcomes.
Importantly, this study also has strengths: the sample
is large and it was controlled for potential confounders.
In addition, this data is potentially relevant for public
health measures because it could address some unre-
solved issues including the influence of GWG on mater-
nal and neonatal outcomes of obese pregnant women
with GDM.
Conclusion
In obese women with GDM, a reduced GWG (<5 kg) is
associated with better obstetric and neonatal outcomes
than an excessive or even an adequate GWG (the ideal
GWG for these women is less than the ideal for non-
diabetic obese women). Thus, specific recommendations
for obese women with GDM should be created because
GWG could be a modifiable risk factor for adverse ob-
stetric outcomes. Instructing women about appropriate
GWG and implementing effective strategies (like diet
adjustment and increased physical activity) to obtain the
minimum GWG could help optimize maternal and peri-
natal outcomes.
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